Compounds > erythrosine

erythrosine and raltegravir potassium

erythrosine has been researched along with raltegravir potassium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamada, A; Hashiguchi, Y; Jono, H; Saito, H; Shinohara, T; Tsuchiya, K1
Arimany-Nardi, C; Cedeño, S; Clotet, B; Erkizia, I; Martinez-Picado, J; Minuesa, G; Moltó, J; Pastor-Anglada, M1

Other Studies

2 other study(ies) available for erythrosine and raltegravir potassium

ArticleYear
Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
    Biochemical and biophysical research communications, 2013, Sep-20, Volume: 439, Issue:2

    Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; CD4-Positive T-Lymphocytes; Cell Line; Fluoresceins; Humans; Intestinal Mucosa; Pyrrolidinones; Raltegravir Potassium; Swine; Transfection

2013
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzylidene Compounds; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Fluoresceins; Healthy Volunteers; HIV Infections; HIV-1; Humans; Immunologic Memory; Raltegravir Potassium; Ritonavir; Tetrahydroisoquinolines; Viral Load; Viremia; Virus Replication

2016